Answers are grounded in this paper and cite their sources.
Laboratory study reveals distinct distribution of p23,30 antigen across normal and leukemic human cells, indicating clear molecular subtypes in leukemia.
Antiserum to a glycoprotein antigen complex of 23,000 and 30,000 dalton subunits (p23,30), isolated and purified from a human lymphoblastoid B cell line, was shown to be highly specific for human bursal-equivalent-processed (B) cells, reactive with 15-20% of human Null cells, but completely unreactive with human thymus-processed (T) cells. The p23,30 antigen is widely distributed on chronic lymphatic leukemic cells, 85% of acute lymphatic leukemic cells, all acute myelogenous leukemic cells, but not on chronic myelogenous leukemic cells. A rabbit antiserum specific for normal human thymocytes has also been prepared; it is reactive only with precisely that subset of acute lymphatic leukemic cells (15%) whose members do not have p23,30 on their surfaces.
No takes yet. Share an insight, caveat, or question.
Schlossman et al. (1976) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: